Redoxis AB Email Format

Research ServicesSkåne, Sweden11-50 Employees

Redoxis AB is a preclinical contract research organization focused on inflammation and autoimmune diseases. It conducts in vivo, ex vivo, and in vitro preclinical efficacy and mechanism-of-action studies, supported by a fully equipped laboratory capable of a broad range of cell-based and immunology assays.

Based in Lund, in the Skåne region of Sweden, the company serves researchers seeking preclinical evaluation of therapies targeting inflammatory and autoimmune conditions. As a small to mid-sized player in the research services industry, it provides end-to-end preclinical support, including MoA work, pharmacokinetics, and in vivo efficacy studies. In early 2022, Redoxis joined forces with Amarna Therapeutics on the ALPHAVAC project to develop a screening platform intended to identify and validate self-antigens in neurodevelopmental disorders.

Get verified Redoxis AB emails free

Company overview Employee directory